AlgoTx
PrivateLast Round
Series B
Mar 14, 2023
Total Funding Raised
$39.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AlgoTx is a biotechnology company that develops targeted, first-in-class therapeutics for peripheral neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlgoTx Comparables
Compare AlgoTx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 上海赛默罗生物科技有限公司 | 79% | |
| Pharmaleads | 77% | |
| PharmNovo AB | 70% |
AlgoTx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 14, 2023 | ||||
| Series A | Nov 24, 2020 | ||||
| Grant | Nov 20, 2019 | ||||
| Seed | Jan 4, 2019 |
AlgoTx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Turenne Groupe | Series B |
| Turenne Capital Partenaires | Series B |
| Omnes Capital | Series A, Series B |
| Sofimac Investment Managers | Series B |
| Bpifrance | Grant, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 92% MoM, reaching 1.9K.
- Apr 17, 2026
Monthly visitors increased 284% MoM, reaching 4.5K.
AlgoTx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access